The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
Open Access
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 116 (2), 248-253
- https://doi.org/10.1016/s0016-5085(99)70119-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A United States multicentre trial of dual and proton pump inhibitor‐based triple therapies for Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 1997
- Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.Gut, 1997
- Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patientsAlimentary Pharmacology & Therapeutics, 1997
- The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infectionJournal of Antimicrobial Chemotherapy, 1997
- Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment ofHelicobacter pyloriDigestive Diseases and Sciences, 1996
- Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I StudyHelicobacter, 1996
- Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juiceGastroenterology, 1996
- Rapid eradication of Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 1995
- Effect of varying pH on the susceptibility ofCampylobacter pylori to antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Does Omeprazole Improve Antimicrobial Therapy Directed Towards Gastric Campylobacter Pylori in Patients with Antral Gastritis?: A Pilot StudyScandinavian Journal of Gastroenterology, 1989